SOPHiA DDM™ for Blood Cancers

More than 1.2 million people worldwide were diagnosed with blood cancer in 2020.1 Accurately identifying molecular alterations within the extensively heterogeneous landscape of blood cancer disorders can contribute to improved prognosis and disease management.

READ MORE